These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Design, synthesis, anti-inflammatory, cytotoxic and cell based studies of some novel side chain analogues of myrrhanones A & B isolated from the gum resin of Commiphora mukul. Mallavadhani UV, Chandrashekhar M, Shailaja K, Ramakrishna S. Bioorg Chem; 2019 Feb; 82():306-323. PubMed ID: 30399528 [Abstract] [Full Text] [Related]
6. Synthesis and biological evaluation of new benzimidazole-1,2,3-triazole hybrids as potential α-glucosidase inhibitors. Asemanipoor N, Mohammadi-Khanaposhtani M, Moradi S, Vahidi M, Asadi M, Faramarzi MA, Mahdavi M, Biglar M, Larijani B, Hamedifar H, Hajimiri MH. Bioorg Chem; 2020 Jan; 95():103482. PubMed ID: 31838286 [Abstract] [Full Text] [Related]
13. Design, synthesis and molecular docking studies of novel N-benzenesulfonyl-1,2,3,4-tetrahydroisoquinoline-based triazoles with potential anticancer activity. Pingaew R, Mandi P, Nantasenamat C, Prachayasittikul S, Ruchirawat S, Prachayasittikul V. Eur J Med Chem; 2014 Jun 23; 81():192-203. PubMed ID: 24836071 [Abstract] [Full Text] [Related]
14. Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents. Duan YC, Ma YC, Zhang E, Shi XJ, Wang MM, Ye XW, Liu HM. Eur J Med Chem; 2013 Apr 23; 62():11-9. PubMed ID: 23353743 [Abstract] [Full Text] [Related]
15. Design, synthesis, in vitro, and in silico studies of novel diarylimidazole-1,2,3-triazole hybrids as potent α-glucosidase inhibitors. Saeedi M, Mohammadi-Khanaposhtani M, Asgari MS, Eghbalnejad N, Imanparast S, Faramarzi MA, Larijani B, Mahdavi M, Akbarzadeh T. Bioorg Med Chem; 2019 Dec 01; 27(23):115148. PubMed ID: 31679980 [Abstract] [Full Text] [Related]